VF
ALXN

Virtu Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Virtu Financial’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,356
Closed -$1.17M – 2346
2021
Q2 		$1.17M Buy
+6,356
New +$1.09M 0.11% 162
2020
Q3 		– Sell
-19,366
Closed -$2.17M – 1747
2020
Q2 		$2.17M Buy
+19,366
New +$2.06M 0.25% 79
2019
Q4 		– Sell
-22,925
Closed -$2.25M – 1999
2019
Q3 		$2.25M Buy
+22,925
New +$2.58M 0.18% 103
2019
Q1 		– Sell
-26,453
Closed -$2.58M – 2044
2018
Q4 		$2.58M Buy
+26,453
New +$3.13M 0.14% 98
2017
Q4 		– Sell
-15,923
Closed -$2.23M – 3235
2017
Q3 		$2.23M Buy
+15,923
New +$2.16M 0.11% 150
2016
Q4 		– Sell
-2,373
Closed -$291K – 600
2016
Q3 		$291K Buy
+2,373
New +$305K 0.05% 278
2016
Q1 		– Sell
-2,964
Closed -$565K – 543
2015
Q4 		$565K Buy
+2,964
New +$518K 0.08% 212
2015
Q3 		– Sell
-3,153
Closed -$570K – 430
2015
Q2 		$570K Buy
+3,153
New +$544K 0.05% 193
2015
Q1 		– Sell
-1,776
Closed -$329K – 420
2014
Q4 		$329K Sell
1,776
-163
-8% -$30.2K 0.04% 234
2014
Q3 		$322K Buy
+1,939
New +$318K 0.03% 222
2014
Q2 		– Sell
-3,506
Closed -$533K – 483
2014
Q1 		$533K Buy
3,506
+1,748
+99% +$278K 0.07% 199
2013
Q4 		$234K Buy
+1,758
New +$211K 0.02% 227

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Virtu Financial's ALXN Position: Q3 2021 in Review

Virtu Financial sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 6,356 shares — an estimated $1.17M sold.

Virtu Financial first reported a position in ALXN in Q4 2013 and held it in 12 quarters. The position peaked at $2.58M in Q4 2018. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Virtu Financial reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Virtu Financial sold 6,356 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.17M.
  • Virtu Financial first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 12 quarters.
  • Virtu Financial's Alexion Pharmaceuticals position peaked at $2.58M in Q4 2018.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Virtu Financial's 13F filing for Q3 2021, filed 12 Nov 2021.